Physician profile
Kent Lyle Walker
NPI 1285989368
$81,987.22
in general payments reported to CMS, 2019-2025
26 companies · $7,932 in 2025
The $7,932 reported for 2025 was more than what 90% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,261 · 2020: $5,251 · 2021: $9,685 · 2022: $11K · 2023: $28K · 2024: $18K · 2025: $7,932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $21K · Food and Beverage: $4,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,250.00 |
| Travel and Lodging | $21,254.92 |
| Food and Beverage | $4,370.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $26,890.85 | 2019-2025 | |
| Medacta USA, INC. | $22,321.74 | 2021-2023 | Myspine, Must |
| Implanet America, INC. | $7,756.32 | 2024-2025 | |
| Alphatec Spine, INC | $7,067.39 | 2023-2024 | Other - Miscellaneous, Invictus Open, Solus Alif |
| Arthrex, INC. | $5,875.76 | 2020-2021 | |
| Alpha Orthopedic Systems | $4,967.44 | 2019-2024 | |
| Depuy Synthes Products, INC. | $1,800.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $1,535.58 | 2019-2021 | |
| Mirus, LLC | $909.84 | 2022 | |
| Medtronic, INC. | $805.58 | 2022-2025 | Mazor X System, Unid_pass, Cd Horizon Spinal System |
| Surgical Theater. INC. | $325.34 | 2024 | |
| Depuy Synthes Sales INC. | $283.11 | 2019-2022 | |
| Nuvasive Specialized Orthopedics, INC. | $265.49 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| 7d Surgical Ulc | $239.28 | 2021 | |
| Blue Surgical LLC | $175.93 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $145.36 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Sanara Medtech INC. | $123.15 | 2022 | |
| Biomarin Pharmaceutical INC. | $121.35 | 2024 | Voxzogo 1.2mg |
| Medical Device Business Services, INC. | $112.47 | 2022 | |
| Medtronic USA, INC. | $89.47 | 2019 | |
| Smith+Nephew, INC. | $73.57 | 2019-2023 | Pico 14, Renasys Touch, Pico 7 |
| Stryker Corporation | $50.25 | 2020 | |
| Kerecis Limited | $18.25 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Okami Medical, INC. | $13.54 | 2024 | Lobo |
| Paragon 28, INC. | $12.71 | 2021 | |
| My01 INC. | $7.45 | 2024 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.